Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Targeting peptides and positron emission tomography.

Hans Lundqvist1, Vladimir Tolmachev

  • 1Department of Oncology, Radiology and Clinical Immunology, Biomedical Radiation Sciences Division, Uppsala University, Uppsala, Sweden. Hans.Lundqvist@bms.uu.se

Biopolymers
|March 27, 2003
PubMed
Summary

Radiolabeled peptides are advancing nuclear medicine diagnostics and therapy. This review explores novel positron-emitting isotopes for peptide labeling in positron emission tomography (PET) to improve tumor imaging and dosimetry.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Engineering a conditionally active cetuximab prodrug via affibody-based paratope masking.

Journal of biological engineering·2026
Same author

Tumour accumulation of anti-carcinoembryonic antigen affibody-albumin-binding domain fusion depends on domains' order.

International journal of biological macromolecules·2026
Same author

The Use of Glycine-Containing Peptide-Based Chelators for Labeling with <sup>99m</sup>Tc Improves the Imaging Properties of EpCAM-Targeting Designed Ankyrin Repeat Ec1.

Molecular pharmaceutics·2026
Same author

Efficient <sup>68</sup>Ga Labeling of a B7-H3-Targeting Affibody Molecule via Acyclic Tris(hydroxypyridinone) Chelator: Effects on Biodistribution in a Preclinical Model.

International journal of molecular sciences·2026
Same author

Exploring the theranostic potential of two metabolically stable GRPR-targeting peptides labelled with Ga-68 for PET imaging.

EJNMMI radiopharmacy and chemistry·2026
Same author

Design of 3D spheroid models for drug-response studies of HER2-targeted radiopharmaceuticals.

Biomaterials advances·2025

Area of Science:

  • Nuclear Medicine
  • Radiochemistry
  • Molecular Imaging

Background:

  • Biologically active peptides are established in SPECT diagnostics and radionuclide therapy.
  • Positron emission tomography (PET) offers quantitative peptide distribution data for improved dosimetry.
  • The rise of PET systems fuels research into alternative peptide labeling strategies.

Purpose of the Study:

  • To review the current status of nonconventional positron emitters for peptide labeling.
  • To assess the potential of various radionuclides for peptide-based diagnostics and therapy using PET.

Main Methods:

  • Review of existing literature on radiolabeled peptides and positron emitters.
  • Analysis of radionuclide properties (physical, nuclear, chemical) for peptide labeling.

Related Experiment Videos

  • Comparison of different labeling approaches (halogens, metal ions) for PET applications.

    • Main Results:

    • Fluorine-18 ((18)F) shows promise but faces labeling challenges.
    • Halogens like Bromine (Br) and Iodine (I) offer easier chemical application.
    • Positron-emitting metal ions (e.g., Cobalt-55 (55Co), Gallium-68 (68Ga)) provide superior intracellular retention but have availability issues.

    Conclusions:

    • Nonconventional positron emitters are crucial for advancing peptide-based PET imaging.
    • Metal-based radionuclides offer advantages in signal-to-background ratio for peptide targeting.
    • Further research is needed to overcome production and availability challenges for clinical translation.